Zardavas, Dimitrios
Irrthum, Alexandre
Swanton, Charles
Piccart, Martine
Article History
First Online: 21 April 2015
Competing interests
: M.P. is a board member for PharmaMar and receives consultant honoraria from Amgen, Astellas, AstraZeneca, Bayer, Eli Lilly, Invivis, MSD, Novartis, Pfizer, Roche-Genentech, sanofi Aventis, Symphogen, Synthon, Verastem. The other authors declare no competing interests